Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

809129

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	What recent assessment he has made of trends in the level of fines in relation to dental and prescription charges.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	903036
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The NHS Business Services Authority (NHS BSA) issues penalty charge notices (PCNs) for incorrect claims for exemption from National Health Service dental and prescription charges.</p><p>To ensure the integrity of the exemption system the NHS BSA has recently increased the number of checks. In 2016/17, 365,181 PCNs for dental charges and 975,065 for prescription charges were issued. This represents an increase of 90.11% and 90.23%, respectively, on 2015/16. There is a clear process for patients to appeal a PCN if they believe it is unjustified.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:09:22 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

837681

	registered interest
	date	06/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Labour Turnover
	house id	1
	legislature	25259 pref label House of Commons
	question text	What estimate his Department has made of the number of GPs who plan to leave general practice in the next five years; and if he will make a statement.
	tabling member constituency	Rochdale
	tabling member printed	Tony Lloyd
	uin	903795
	answer	answer is ministerial correction date of answer 06/02/2018 answer text <p>We know that one of the main reasons GPs leave general practice is retirement. That is why we have put in place comprehensive measures to ensure we meet our commitment of an extra 5,000 GPs in the NHS by 2020. GP Career Plus, the GP Retention Scheme and the National GP Induction and Refresher Scheme will all help get valuable experienced GPs back into our NHS. 3,157 GP training places were also filled in 2017 – the highest number ever.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/02/2018 15:44:28 answering member 4067 label Biography information for Steve Brine
	tabling member	450 label Biography information for Tony Lloyd

809126

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Skin Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	What estimate he has made of the number of patients with Erythropoietic Protoporphyria.
	tabling member constituency	Newport East
	tabling member printed	Jessica Morden
	uin	903031
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>In 2016/17 there were 54 National Health Service admissions in England with a primary diagnosis of Erythropoietic Protoporphyria.</p><p> </p><p>Whilst the numbers of people with a particular rare disease can be very small, 3.5 million people in the United Kingdom have a rare disease. We know, as with the hon. Member’s constituent, that these diseases can have a heart-breaking impact on a person’s health.</p><p> </p><p>That‘s why the UK is committed to building on our position as a world-leader in the diagnosis and treatment of rare diseases.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:07:30 answering member 4067 label Biography information for Steve Brine
	tabling member	1548 label Biography information for Jessica Morden

828794

	registered interest
	date	23/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Kidney Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State, if he will take steps to ensure that people with diabetes are offered urine and blood tests to check for chronic kidney disease.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	124426
	answer	answer is ministerial correction date of answer 31/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has published guidance on ‘Chronic kidney disease in adults’ which sets out best practice for clinicians on the diagnosis, treatment, care, and support of patients with chronic kidney disease (CKD). The guidance also includes recommendations for those at risk of developing CKD, including people with diabetes. NHS England expects commissioners to take account of NICE guidelines when delivering services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/01/2018 12:34:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

818651

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Government response to the Accelerated Access Review published in November 2017, what plans his Department has to streamline existing routes to market for medical technologies, devices and diagnostics.
	tabling member constituency	East Kilbride, Strathaven and Lesmahagow
	tabling member printed	Dr Lisa Cameron
	uin	121415
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>We are introducing a new Accelerated Access Pathway, to streamline regulatory and market access decisions, getting breakthrough products that we believe will be truly transformative to patients more quickly. A new Accelerated Access Collaborative (AAC) chaired by Sir Andrew Witty, will develop and own the Accelerated Access Pathway which will be operational from April 2018. All products including medical technologies, devices and diagnostics will be eligible for selection. In addition to the new Pathway, the AAC will also make recommendations to the Government and its partners about opportunities to further streamline existing routes to market.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/01/2018 12:04:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4412 label Biography information for Dr Lisa Cameron

818756

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	High Weald Lewes Havens Clinical Commissioning Group
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Answer of 8 November 2016 to Question 51429, if he will publish a copy of the validated analysis of costs provided by Coperforma Ltd to the High Weald Havens Clinical Commissioning Group referred to in that Answer; what the value is of invoices the High Weald Havens Clinical Commissioning Group received directly from each trust which incurred private ambulance costs arising from performance problems with Patient Transport Services provided by Coperforma and arms length driver operatives; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	121520
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121516 121517 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
	tabling member	3930 label Biography information for Caroline Lucas

809659

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to Age UK’s Painful Journeys campaign, what steps his Department is taking to make travelling to and from hospital easier for older people.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	120279
	answer	answer is ministerial correction date of answer 27/12/2017 answer text <p>The provision of appropriate patient transport services (PTS) in line with national guidance is a matter for local National Health Service commissioners.</p><p> </p><p>The Department is clear that medically eligible patients must have appropriate access to quality PTS to outpatient appointments. The document ‘Eligibility Criteria for Patient Transport Services’ sets out criteria for establishing which patients are eligible for non-emergency PTS. The guidance states that eligible patients should reach appointments in reasonable time and in reasonable comfort, without detriment to their medical condition.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/12/2017 11:03:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4058 label Biography information for Paul Blomfield

810724

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accountable Care Organisations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, who is responsible for determining the membership of an Accountable Care Organisation.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	121069
	answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>In the very small number of places where local commissioners are running procurements for the award of such contracts, local National Health Service foundation trusts, NHS trusts and general practitioners have been selected as partners for delivery of those contracts.</p><p> </p><p>The selection of an appropriate provider to hold such a contract will continue to be a matter for local NHS commissioners, and those commissioners must make that selection by way of a process which is compliant with the requirements of the Public Contract Regulations 2015. These involve openness, transparency and equal treatment of potential providers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120591 question first answered 11/01/2018 16:52:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

816943

	registered interest
	date	05/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups: Sponsorship
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which Clinical Commissioning Groups have a policy of not accepting sponsorship from drug companies and similar organisations; and whether his Department plans to regulate or stop such sponsorship arrangements.
	tabling member constituency	Preston
	tabling member printed	Sir Mark Hendrick
	uin	121370
	answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>NHS England does not collect data centrally on which clinical commissioning groups (CCGs) have a policy of not accepting sponsorship from drug companies and similar organisations. NHS England published statutory guidance on managing conflicts of interest for CCGs in June 2017 which aims to support CCGs to identify and manage a range of conflicts of interests, which is available at the following link:</p><p> </p><p>https://www.england.nhs.uk/wp-content/uploads/2017/06/revised-ccg-coi-guidance-jul-17.pdf</p><p> </p><p>This guidance addresses the issue of sponsorship. In addition, NHS England published system-wide guidance in February 2017 on managing conflicts of interest in the NHS which is available at the following link:</p><p> </p><p>https://www.england.nhs.uk/wp-content/uploads/2017/02/guidance-managing-conflicts-of-interest-nhs.pdf</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:39:53 answering member 4067 label Biography information for Steve Brine
	tabling member	473 label Biography information for Sir Mark Hendrick

810702

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	EU Rapid Alert Systems for Food and Feed
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the UK will continue to participate in the EU Rapid Alert Systems for Food and Feed after the UK leaves the EU.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Luke Pollard
	uin	121047
	answer	answer is ministerial correction date of answer 08/01/2018 answer text <p>The Rapid Alert System for Food and Feed is important in enabling the management of food and feed safety risks by providing early alerts of health or food contamination issues across the European Union. At present, this enables the United Kingdom to respond quickly to serious risks to public health relating to food and animal feed. The Government is considering the best approach for the management of notification of food and feed safety risks once we have left the EU. It will be our priority to maintain the UK’s high standards of food and feed safety, and continue to be able to provide a timely response to food safety incidents. This is essential for the protection of public health, and for maintaining consumer confidence in food.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/01/2018 16:36:22 answering member 4067 label Biography information for Steve Brine
	tabling member	4682 label Biography information for Luke Pollard